Skip to main content
. 2019 Nov 10;34(2):197–203. doi: 10.15605/jafes.034.02.11

Table 4.

Univariate logistic regression analysis on the association of socioeconomic status and clinical factors with depression among patients with type 2 diabetes mellitus

Variable Odds Ratio 95% CI p-value
Age (Mean±SD)
0.964
0.944 - 0.984
0.001*
Gender
 Male Ref
 Female
2.102
1.179-3.749
0.012*
Marital Status
 Never married Ref
 Married 0.538 0.286-1.015 0.055
 Widowed
1.018
0.416-2.491
0.969
Educational Status
 Elementary Ref
 High School 2.657 0.847-52.312 0.071
 College/Vocational 4.278 0.567-32.267 0.159
 Post graduate
12.789
1.493-109.544
0.020*
Employment
 Not employed Ref
 Employed
1.273
0.773-2.097
0.343
BMI
0.952
0.900-1.007
0.090
BMI category
 Normal Ref
 Underweight 4.583 1.250-16.799 0.022*
 Overweight 1.925 0.883-4.120 0.100
 Obese
0.902
0.446-1.823
0.774
Duration of Diabetes
 <1 year Ref
 1-5 years 0.423 0.179-0.999 0.050*
 6-10 years 0.345 0.134-0.884 0.027*
 >10 years
0.551
0.241-1.257
0.157
HbA1c (Mean±SD)
1.269
1.093-1.372
0.002*
DM control
 Controlled Ref
 Uncontrolled
1.928
1.125-3.303
0.017*
Complications
 Retinopathy 1.800 1.027-3.022 0.026*
 Nephropathy 1.131 0.651-1.967 0.661
 Neuropathy 1.582 0.959-2.610 0.072
 Stroke 0.557 0.192-1.610 0.280
 CAD 0.333 0.101-1.099 0.071
 PAOD
0.876
0.296-2.597
0.812
Number of Medications
1.119
0.900-1.392
0.309
Medications
 Insulin 1.363 0.810-2.294 0.244
 Biguanides 0.849 0.491-1.466 0.556
 Sulfonylureas 1.021 0.578-1.804 0.942
 DPP-IV inhibitors 0.979 0.584-1.641 0.937
 SGLT-2 inhibitors 1.471 0.853-2.535 0.165
 TZD
1.209
0.561-2.604
0.628
Comorbidities
 Hypertension 0.535 0.324-0.884 0.015*
 Dyslipidemia 0.675 0.409-1.116 0.125
 Hyperuricemia 0.297 0.039-2.260 0.241
 Hypothyroidism
1.402
0.455-4.320
0.556
Morisky Medication Adherence
 Low Ref
 Medium 0.426 0.233-0.778 0.005*
 High
0.241
0.125-0.464
0.000*
Morisky Medication Adherence 1.418 1.245-1.614 <0.001*
 Score

BMI, Body Mass Index; DM, Diabetes Mellitus; CAD, Coronary Artery Disease; PAOD, Peripheral Arterial Occlusive Disease

*

Significant at 0.05 level